ARKG Investment Tracker position change: Decreased position in Natera by 18,144 shares, the number of shares held decreased 4.63% compared to the previous period and now represents 6.03% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 74,172 shares, the number of shares held decreased 4.64% compared to the previous period and now represents 7.1% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 102,186 shares, the number of shares held decreased 4.64% compared to the previous period and now represents 6.25% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 44,562 shares, the number of shares held decreased 4.64% compared to the previous period and now represents 2.97% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 382,835 shares, the number of shares held decreased 3.37% compared to the previous period and now represents 1.42% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 485 shares, the number of shares held decreased 0.86% compared to the previous period and now represents 1.75% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 118,385 shares, the number of shares held decreased 3.97% compared to the previous period and now represents 2.58% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 62,832 shares, the number of shares held decreased 4.63% compared to the previous period and now represents 6.26% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 48,132 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 2.48% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 102,144 shares, the number of shares held decreased 4.64% compared to the previous period and now represents 8.25% of the total position.